88 related articles for article (PubMed ID: 8508471)
21. Simultaneous determination of enalapril and enalaprilat in human plasma by liquid chromatography-tandem mass spectrometry.
Gu Q; Chen X; Zhong D; Wang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):337-42. PubMed ID: 15556550
[TBL] [Abstract][Full Text] [Related]
22. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs.
Nishiyama S; Kanno K; Yoneda H; Yano K; Yamaguchi I
Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673
[TBL] [Abstract][Full Text] [Related]
23. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study.
Jain DS; Subbaiah G; Sanyal M; Pande UC; Shrivastav P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):92-100. PubMed ID: 16709467
[TBL] [Abstract][Full Text] [Related]
24. The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction.
Oshima S; Ogawa H; Mizuno Y; Yamashita S; Noda K; Saito T; Sumida H; Suefuji H; Kaikita K; Soejima H; Yasue H
Am Heart J; 1997 Nov; 134(5 Pt 1):961-6. PubMed ID: 9398110
[TBL] [Abstract][Full Text] [Related]
25. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 3rd communication: tissue accumulation after consecutive oral administration of [N-methyl-14C]-imidapril in rats.
Yamada Y; Endo M; Kohno M; Suzuki T; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):475-82. PubMed ID: 1642670
[TBL] [Abstract][Full Text] [Related]
26. Effects of the new angiotensin-I-converting enzyme inhibitor imidapril on the responses of isolated vascular preparations to various agonists.
Kubo M; Fujitsuka T; Ishida R
Arzneimittelforschung; 1992 Apr; 42(4):446-51. PubMed ID: 1642667
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of losartan, EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-well-format-based solid-phase extraction and liquid chromatography-negative electrospray tandem mass spectrometry.
Kolocouri F; Dotsikas Y; Apostolou C; Kousoulos C; Loukas YL
Anal Bioanal Chem; 2007 Jan; 387(2):593-601. PubMed ID: 17119933
[TBL] [Abstract][Full Text] [Related]
28. Determination of a new angiotensin-converting enzyme inhibitor (CS-622) and its active metabolite in plasma and urine by gas chromatography-mass spectrometry using negative ion chemical ionization.
Shioya H; Shimojo M; Kawahara Y
J Chromatogr; 1989 Nov; 496(1):129-35. PubMed ID: 2592507
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats.
Sasaki Y; Noguchi T; Seki J; Giddings JC; Yamamoto J
Thromb Haemost; 2000 May; 83(5):722-7. PubMed ID: 10823269
[TBL] [Abstract][Full Text] [Related]
30. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 2nd communication: tissue distribution and whole-body autoradiography of imidapril in rats.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):466-74. PubMed ID: 1642669
[TBL] [Abstract][Full Text] [Related]
31. An improved method for the measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry.
Leis HJ; Fauler G; Raspotnig G; Windischhofer W
Rapid Commun Mass Spectrom; 1999; 13(8):650-3. PubMed ID: 10343410
[TBL] [Abstract][Full Text] [Related]
32. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
[TBL] [Abstract][Full Text] [Related]
33. Effects of imidapril, an angiotensin-converting enzyme inhibitor, on insulin sensitivity and responsiveness in streptozotocin-induced diabetic rats.
Viana AY; Oshida Y; Han YQ; Koshinaka K; Sato Y
Horm Metab Res; 2004 Jan; 36(1):34-8. PubMed ID: 14983404
[TBL] [Abstract][Full Text] [Related]
34. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.
Chen R; Iwai M; Wu L; Suzuki J; Min LJ; Shiuchi T; Sugaya T; Liu HW; Cui TX; Horiuchi M
Hypertension; 2003 Oct; 42(4):542-7. PubMed ID: 12963679
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
[TBL] [Abstract][Full Text] [Related]
36. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
Harder S; Thürmann PA; Ungethüm W
Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
[TBL] [Abstract][Full Text] [Related]
37. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 4th communication: placental transfer and secretion into milk in rats.
Endo M; Yamada Y; Kohno M; Suzuki T; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):483-9. PubMed ID: 1642671
[TBL] [Abstract][Full Text] [Related]
38. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
Li P; Kondo T; Numaguchi Y; Kobayashi K; Aoki M; Inoue N; Okumura K; Murohara T
Hypertension; 2008 Feb; 51(2):252-8. PubMed ID: 18086946
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous determination of FLZ and its metabolite (M1) in human plasma and urine by UHPLC-MS/MS: Application to a pharmacokinetic study.
Cui C; Chen R; Jiang J; Liu R; Wang W; Zhao Q; Hu P
J Pharm Biomed Anal; 2019 Feb; 164():32-40. PubMed ID: 30342394
[TBL] [Abstract][Full Text] [Related]
40. A 24-week dose-titration study of the angiotensin-converting enzyme inhibitor imidapril in the treatment of mild-to-moderate essential hypertension in the elderly.
Dews I; VandenBurg M
J Int Med Res; 2001; 29(2):100-7. PubMed ID: 11393342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
